Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse
- 6 July 1987
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 41 (1), 103-110
- https://doi.org/10.1016/0024-3205(87)90562-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Direct determination of folate monoglutamates in plasma by high-performance liquid chromatography using an automatic precolumn-switching system as sample clean-up procedureJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- Teratogenic valproic acid concentrations: Infusion by implanted minipumps vs conventional injection regimen in the mouseToxicology and Applied Pharmacology, 1985
- Neural‐tube defects and vitamins: the need for a randomized clinical trialBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome.BMJ, 1983
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- Apparent prevention of neural tube defects by periconceptional vitamin supplementation.Archives of Disease in Childhood, 1981
- Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography—mass spectrometry using selected ion monitoringJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.BMJ, 1981
- Teratogenicity of valproic acid: In vivo and in vitro investigationsTeratogenesis, Carcinogenesis, and Mutagenesis, 1981